Women giving birth for the first time have significantly higher odds of developing gestational diabetes if they have a high polygenic risk score (PRS) and low...
The US Food and Drug Administration (FDA) has approved the biologic agent spesolimab (Spevigo) for the treatment of flares in adults with generalized pustular psoriasis (GPP),...
Early use of the SGLT2 inhibitor empagliflozin (Jardiance) after an acute myocardial infarction (MI) improves natriuretic peptide levels and markers of cardiac function and...
The U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with...